Piramal Enterprises Ltd logo

Piramal Enterprises Ltd

NSE : PEL
BSE: 500302
SECTOR : PHARMACEUTICALS
No data to show from BSE
52w high/low icon
52w high/low
₹3014.95 / ₹1303.6
P/E ratio icon
P/E ratio
135.04
Dividend icon
Dividend
1.65
ROE icon
ROE
1.11
ROCE icon
ROCE
3.65
Face value icon
Face value
2
Book value icon
Book value
₹962.9Cr
Market capital icon
Market capital
₹45,217.22Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.
Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:
Assets = Liabilities + Shareholder's Equity
This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM
135.04
P/B
1.97
ROE
1.11
ROCE
3.65
Dividend yield
1.65%
EPS TTM
14.45
EBTIDA Growth
-47.86
D/E
0.37
Sector PE
36.56
BV
₹962.9Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.
Piramal Enterprises Ltd logo

About Piramal Enterprises Ltd

Piramal Enterprises Limited (PEL), erstwhile Piramal Healthcare Limited, is the flagship company of the Piramal Group, led by Ajay Piramal. Piramal Enterprises Limited (PEL) is one of India's large diversified companies, with a presence in Financial Services, Pharmaceuticals and Healthcare Insights & Analytics. The company derived around 46% of its revenue from outside India during the financial year ended 31 March 2018. In Pharma, through an end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated Pharma products and provides an entire pool of Pharma services (including in the areas of injectable, HPAPI etc. ). PEL's Global Pharma business has a strong product portfolio of niche differentiated branded generic products that are difficult to manufacture, sell or distribute. PEL's Contract Development and Manufacturing Organisation (CDMO) services segment offers end-to-end solutions across the drug life cycle through a globally integrated network of facilities. PEL's India consumer products division caters to the Indian self-care market.

Key info

Address
Piramal Ananta Agastya Corp Pa, LBS Marg Kurla (W), Mumbai, Maharashtra, 400070
Fax Nos.
91-22-3802 3084
Telephone Nos.
91-22-3802 3083/3000/4000
Email
complianceofficer.pel@piramal.com
fbtwitterlinkedingithubinstagramyoutube